14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 26 Jun 2024

Trading levels for AKBA

Fibonacci Support & Resistance Levels

Level Price
R3 0.97 13.40%
R2 0.94 9.44%
R1 0.92 6.99%
Price 0.86
S1 0.85 -0.94%
S2 0.83 -3.39%
S3 0.794 -7.35%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.07 24.90%
R2 0.94 9.72%
R1 0.90 5.49%
Price 0.86
S1 0 -
S2 0 -
S3 0 -

AKBA Predictions History

1 year ago
JS predicted that AKBA for 2023-01-30 is going $0.664 (9.93%)

1 year ago
PredictionBot.Kathy predicted that AKBA for 2023-01-30 is going $0.693 (14.70%)

1 year ago
PredictionBot.Warren predicted that AKBA for 2023-01-30 is going $0.684 (13.28%)

3 years ago
JS predicted that AKBA for 2020-10-30 is going $2.19 (-1.35%)

3 years ago
DeMichael Franklin predicted that AKBA for 2020-10-30 is going $2.00 (-9.91%)

Rank:

3 years ago
JS predicted that AKBA for 2020-10-12 is going $3.22 (3.54%)

3 years ago
iHustle84 predicted that AKBA for 2020-10-12 is going $3.13 (0.64%)

3 years ago
DeMichael Franklin predicted that AKBA for 2020-10-12 is going $2.50 (-19.61%)

Rank:

3 years ago
JS predicted that AKBA for 2020-10-07 is going $2.63 (-6.74%)

3 years ago
iHustle84 predicted that AKBA for 2020-10-07 is going $2.69 (-4.61%)

Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT